The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism

Detalhes bibliográficos
Autor(a) principal: Marouço,Catarina Nazário
Data de Publicação: 2021
Outros Autores: Caeiro,Fernando, Costa,Bernardo Marques da, Navarro,David, Magriço,Rita, Nolasco,Fernando
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123
Resumo: ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels.
id RCAP_68910213c652bea60aba62e0fa5dda4c
oai_identifier_str oai:scielo:S0872-01692021000200123
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidismhypercalcemiaprimary hyperparathyroidismhemodialysis.ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels.Sociedade Portuguesa de Nefrologia2021-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123Portuguese Journal of Nephrology & Hypertension v.35 n.2 2021reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123Marouço,Catarina NazárioCaeiro,FernandoCosta,Bernardo Marques daNavarro,DavidMagriço,RitaNolasco,Fernandoinfo:eu-repo/semantics/openAccess2024-02-06T17:05:10Zoai:scielo:S0872-01692021000200123Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:19:06.084432Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
title The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
spellingShingle The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
Marouço,Catarina Nazário
hypercalcemia
primary hyperparathyroidism
hemodialysis.
title_short The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
title_full The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
title_fullStr The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
title_full_unstemmed The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
title_sort The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
author Marouço,Catarina Nazário
author_facet Marouço,Catarina Nazário
Caeiro,Fernando
Costa,Bernardo Marques da
Navarro,David
Magriço,Rita
Nolasco,Fernando
author_role author
author2 Caeiro,Fernando
Costa,Bernardo Marques da
Navarro,David
Magriço,Rita
Nolasco,Fernando
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Marouço,Catarina Nazário
Caeiro,Fernando
Costa,Bernardo Marques da
Navarro,David
Magriço,Rita
Nolasco,Fernando
dc.subject.por.fl_str_mv hypercalcemia
primary hyperparathyroidism
hemodialysis.
topic hypercalcemia
primary hyperparathyroidism
hemodialysis.
description ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology & Hypertension v.35 n.2 2021
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137280780140544